triple glp-1/gip/glucagon receptor agonist

triple glp-1/gip/glucagon receptor agonist Dual GLP-1 / GIP (CAS 2023788-19-2) Targeting GLP-1, GIP & GCG

Name: triple glp-1/gip/glucagon receptor agonist Dual GLP-1 / GIP (CAS 2023788-19-2) Targeting GLP-1, GIP & GCG
Brand: hrexcellencemena.com
SKU: 29344859798
Price: 29.43 USD
Availability: InStock
Rating: 4.1881 (29 reviews)

SKU: 29344859798

4.2

USD29.43 USD54.43

Pay in 4 interest-free payments of $7.36 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 28 - Oct 3

Description

Tochikubo, K., Yasuda, Y

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease)

Urology Annals 2013

& Spires-Jones, T